References
- Mancia G, DeBacker G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105–87
- Brennan F, Flanagan M, Blake S, Cannon P. Nifedipine in the treatment of hypertension. Eur J Clin Pharmacol 1983;25:713–15
- Gradman AH, Basile JN, Carter BL, et al. Combination therapy in hypertension. J Am Soc Hypertens 2010;4:90–8
- Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 2004;364:849–57
- Hasebe N, Kikuchi K. Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study. J Hypertens 2005;23:445–53
- Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000;356:366–72
- Saito I, Saruta T. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the Adalat CR and Valsartan cost-effectiveness combination (ADVANCE-combi) study. Hypertens Res 2006;29:789–96
- Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27:2121–58
- National Institute for Health and Clinical Excellence: Clinical Management of Primary Hypertension in Adults. NICE Guidelines [CG127]. UK National Institute for Health and Clinical Excellence (NICE) Clinical Guideline. Available from: http://publications.nice.org.uk/hypertension-cg127 [last accessed 27 April 2015]
- Motaweih AK, Usova E, Hussain W, et al. Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE). BMC Cardiovasc Disord 2015;15:35
- Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311–21
- European Society of Cardiology: Euro Heart Survey. Cardiovascular diseases in Europe in 2006. Available from: http://www.escardio.org/static_file/Escardio/EORP/about/EHS-CVD-report-2006.pdf [last accessed 27 April 2015]
- Haller H. Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk. Int J Clin Pract 2008;62:781–90
- Neutel JM. The use of combination drug therapy in the treatment of hypertension. Prog Cardiovasc Nurs 2002;17:81–8
- Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–219
- Ueng KC, Ningling S, El MA, et al. Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study. Clin Drug Investig 2011;31:631–42
- Huo Y, Zhang J, He Q, et al. Efficacy and safety of nifedipine GITS in Chinese patients with hypertension--a post-marketing surveillance study. Blood Press Suppl 2007;1:18–23
- Runlin G, Junren Z, Guozhang L, et al. Efficacy and safety of nifedipine GITS in Asians with hypertension: results of a post-marketing surveillance study in China. Clin Drug Investig 2007;27:565–72
- Chrysant SG, Sugimoto DH, Lefkowitz M, et al. The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy. Blood Press Suppl 2007;1:10–17
- Messerli FH, Oparil S, Feng Z. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol 2000;86:1182–7
- Kjeldsen SE, Sica D, Haller H, et al; DISTINCT Investigators. Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results. J Hypertens 2014;32:2488–98